{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-24-000176","form_type":"8-K","ticker":"USNA","cik":"0000896264","company_name":"USANA HEALTH SCIENCES INC","filed_at":"2024-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.215984+00:00","generated_at":"2026-06-06T08:50:45.068207+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"USANA Q4 net sales $221M, EPS $0.87; FY2023 sales -8%; FY2024 guidance $850-920M","bullets":["Q4 net sales $221M (-3% YoY, +4% seq); diluted EPS $0.87 (+32% YoY).","FY2023 net sales $921M (-8% YoY); diluted EPS $3.30 (-8% YoY).","FY2024 guidance: net sales $850-920M, diluted EPS $2.40-3.00, down from FY2023.","Greater China active customers +5% YoY, +11% seq; North Asia net sales -10% YoY.","No share repurchases in Q4; $71M remaining authorization; cash $330M."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-24-000176","json":"https://secwatch.observer/filing/0001157523-24-000176.json","markdown":"https://secwatch.observer/filing/0001157523-24-000176.md","text":"https://secwatch.observer/filing/0001157523-24-000176.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/896264/000115752324000176/0001157523-24-000176-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/896264/000115752324000176/a53892955.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T08:50:45.068207+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3cee83a0602f29fa420ab2250e0e249ac685ebcf","claim":"USANA HEALTH SCIENCES INC updated its the fourth quarter and fiscal year ended December 30, 2023 guidance (initiated).","evidence_excerpt":"On February 6, 2024, USANA Health Sciences, Inc. (the “Company” or “USANA”) issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/896264/000115752324000176/0001157523-24-000176-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and fiscal year ended December 30, 2023"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}